Bain Capital, KKR, KV Asia Shortlisted for Minority Stake in Malaysia’s Avisena Healthcare
Advertisement
Binding bids are expected by the end of July. The stake on offer is estimated at 20–25%, with a potential transaction value of RM300 million to RM400 million.
Private equity firms Bain Capital, KKR, and KV Asia Capital have been shortlisted to acquire a minority stake in Malaysia-based Avisena Healthcare, in a transaction that could value the hospital operator at approximately RM1.5 billion (US$368 million), according to people familiar with the matter.
Binding bids are expected by the end of July. The stake on offer is estimated at 20–25%, with a potential transaction value of RM300 million to RM400 million.
Avisena Healthcare serves more than 250,000 local and international patients annually. The company operates in Malaysia’s private healthcare sector, which continues to attract investor interest alongside broader growth across Southeast Asia.
The shortlisted bidders represent a mix of global and regional private equity firms. Bain Capital and KKR are among the world's largest investment firms with significant healthcare portfolios, while KV Asia Capital focuses on investments in mid-sized companies across Southeast Asia.
The proposed transaction reflects continued investor appetite for healthcare assets in the region, supported by rising incomes, aging populations, and increasing demand for private healthcare services.
Malaysia's healthcare sector has witnessed several major investment activities this year. Sunway Healthcare raised RM2.9 billion through an initial public offering, marking the country's largest stock market listing in nine years. Separately, private equity firm TPG has engaged investment banks to evaluate strategic options for Asia OneHealthcare, including a potential sale or initial public offering.
KKR and Bain Capital declined to comment on the reported transaction. Avisena Healthcare and KV Asia Capital had not responded to requests for comment at the time of publication.
If completed, the investment would add to the growing list of private equity transactions targeting healthcare providers across Southeast Asia, as investors continue to seek opportunities in markets driven by expanding healthcare demand and demographic shifts.
Stay tuned for more such updates on Digital Health News